Skip to main content

RT @JAMA_current: The first randomized clinical trial of convalescent plasma in #COVID19, reported by Li et al in JAMA s

Social Author Name
JAMA
Tweet Content
The first randomized clinical trial of convalescent plasma in #COVID19, reported by Li et al in JAMA suggests that high titer antibody against #SARSCoV2 may have antiviral efficacy https://t.co/6YIib2GXGX
Show on Archive Page
On
Display in Search Results
On
×